Modelmole
AI-driven molecular discovery and drug development services for biotechnology and pharmaceutical companies
Highlights
- Young companyFounded 2023
- New on EvolcAdded 2026-11-03
About Modelmole
ModelMole develops an AI drug-discovery platform that combines computational chemistry, physics-based methods and multiple AI systems to design and assess molecular candidates. Its capabilities include de novo design, drug repurposing, candidate intelligence and partner matching.
The company works with clients on a per-project basis, offering its full discovery suite or selected capabilities. It is registered in Orpington, United Kingdom, and was founded in 2023.
Product: An AI drug-discovery platform and project-based services for molecular design, drug repurposing and candidate assessment.
Jobs at Modelmole
Leadership
- Alexander van Teijlingen · Co-founder and DirectorSource: company website
- Matt Beck · Co-founder and DirectorSource: company website
- Ralf Onken · Co-founder and DirectorSource: company website
More biotech & pharma companies
Moolec Science
Produces animal proteins and plant-based ingredients in crops such as soybean and safflower for food companies worldwideNew on EvolcMoredun Scientific
Contract research and biosafety testing for animal health, aquaculture and biopharmaceutical companiesNew on EvolcMyricx Pharma
Develops antibody-drug conjugate cancer therapies using payloads based on N-myristoyltransferase inhibitorsNew on EvolcNanomerics
Develops polymer-based drug and gene delivery technologies for pharmaceutical therapies in ophthalmology and CNS conditionsNew on EvolcNanosyrinx
Develops targeted intracellular delivery of protein therapeutics for biotech and pharmaceutical drug developersNew on EvolcNanovery
DNA nanorobot assays for biotech and life sciences researchers quantifying RNA therapeutics and nucleic acid biomarkersNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- SquarespaceHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
